Healthcare provider profile · identity verified

Marc Bloomenstein, OD

Eye and Vision Services Providers|Optometrist · SCOTTSDALE, AZ · NPI 1568428910

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Marc Bloomenstein, OD received $294,464.50 in general payments during 2025 across 423 reported records.

Tarsus Pharmaceuticals, Inc. accounted for 35.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 21 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Cequa, Miebo, Oxervate, Xdemvy, Xiidra.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Lumigan by this doctor in 2024.

Bausch & Lomb Americas Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MIEBO as an associated drug or biological on 34133 records involving 12967 distinct recipient NPIs. Public Medicare Part D data also shows 52 claims for Miebo by this doctor in 2024.

Bausch & Lomb Americas Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIIDRA as an associated drug or biological on 28163 records involving 11019 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Xiidra by this doctor in 2024.

Dompe US, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported OXERVATE as an associated drug or biological on 19540 records involving 9712 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Oxervate by this doctor in 2024.

SUN PHARMACEUTICAL INDUSTRIES INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Cequa as an associated drug or biological on 25765 records involving 9461 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Cequa by this doctor in 2024.

Tarsus Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XDEMVY as an associated drug or biological on 46638 records involving 15254 distinct recipient NPIs. Public Medicare Part D data also shows 93 claims for Xdemvy by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$294,464.50

423 reported records · 12 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Tarsus Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$103,451.59	35.1%	148	2025
Bausch & Lomb Americas Inc.	Unresolved — no canonical attribution shown	$86,393.39	29.3%	128	2025
Alcon Vision LLC	Unresolved — no canonical attribution shown	$29,637.44	10.1%	44	2025
Dompe US, Inc.	Unresolved — no canonical attribution shown	$24,686.00	8.4%	36	2025
Harrow Eye, LLC	Unresolved — no canonical attribution shown	$17,002.07	5.8%	13	2025
SUN PHARMACEUTICAL INDUSTRIES INC.	Unresolved — no canonical attribution shown	$15,770.95	5.4%	41	2025
Sight Sciences, Inc.	Unresolved — no canonical attribution shown	$6,898.97	2.3%	3	2025
Alcon Research LLC	Unresolved — no canonical attribution shown	$6,375.00	2.2%	2	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$1,706.25	0.6%	4	2025
Glaukos Corporation	Unresolved — no canonical attribution shown	$1,500.00	0.5%	1	2025
TOPCON HEALTHCARE, INC.	Unresolved — no canonical attribution shown	$1,000.00	0.3%	1	2025
RxSight Inc	Unresolved — no canonical attribution shown	$42.84	0.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$104,550.00	28
Compensation for serving as faculty or as a speaker for a medical education program	$103,000.00	33
Consulting Fee	$38,255.22	22
Travel and Lodging	$31,728.47	180
Honoraria	$11,100.00	2
Food and Beverage	$5,830.81	158

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
XDEMVY Normalized: xdemvy	Drug	Tarsus Pharmaceuticals, Inc.	$100,198.28	143	2025
Source payment records 2025-01-08 · Tarsus Pharmaceuticals, Inc. · $14.93 · Open Payments source 2025-01-28 · Tarsus Pharmaceuticals, Inc. · $355.69 · Open Payments source 2025-01-28 · Tarsus Pharmaceuticals, Inc. · $66.00 · Open Payments source 2025-01-28 · Tarsus Pharmaceuticals, Inc. · $83.52 · Open Payments source 2025-01-28 · Tarsus Pharmaceuticals, Inc. · $32.46 · Open Payments source 2025-01-28 · Tarsus Pharmaceuticals, Inc. · $13.52 · Open Payments source 2025-01-28 · Tarsus Pharmaceuticals, Inc. · $508.18 · Open Payments source 2025-01-28 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-01-29 · Tarsus Pharmaceuticals, Inc. · $4.47 · Open Payments source 2025-02-11 · Tarsus Pharmaceuticals, Inc. · $84.44 · Open Payments source 2025-02-11 · Tarsus Pharmaceuticals, Inc. · $43.41 · Open Payments source 2025-02-14 · Tarsus Pharmaceuticals, Inc. · $8.50 · Open Payments source 2025-02-14 · Tarsus Pharmaceuticals, Inc. · $5.08 · Open Payments source 2025-03-06 · Tarsus Pharmaceuticals, Inc. · $454.32 · Open Payments source 2025-03-06 · Tarsus Pharmaceuticals, Inc. · $45.00 · Open Payments source 2025-03-06 · Tarsus Pharmaceuticals, Inc. · $134.95 · Open Payments source 2025-03-06 · Tarsus Pharmaceuticals, Inc. · $6.23 · Open Payments source 2025-03-06 · Tarsus Pharmaceuticals, Inc. · $10.04 · Open Payments source 2025-03-06 · Tarsus Pharmaceuticals, Inc. · $882.35 · Open Payments source 2025-03-06 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-03-07 · Tarsus Pharmaceuticals, Inc. · $303.97 · Open Payments source 2025-03-07 · Tarsus Pharmaceuticals, Inc. · $771.40 · Open Payments source 2025-03-08 · Tarsus Pharmaceuticals, Inc. · $99.96 · Open Payments source 2025-03-08 · Tarsus Pharmaceuticals, Inc. · $49.98 · Open Payments source 2025-03-08 · Tarsus Pharmaceuticals, Inc. · $53.69 · Open Payments source 2025-03-08 · Tarsus Pharmaceuticals, Inc. · $33.00 · Open Payments source 2025-03-08 · Tarsus Pharmaceuticals, Inc. · $5,750.00 · Open Payments source 2025-03-13 · Tarsus Pharmaceuticals, Inc. · $63.00 · Open Payments source 2025-03-13 · Tarsus Pharmaceuticals, Inc. · $168.50 · Open Payments source 2025-03-13 · Tarsus Pharmaceuticals, Inc. · $30.82 · Open Payments source 2025-03-13 · Tarsus Pharmaceuticals, Inc. · $14.55 · Open Payments source 2025-03-13 · Tarsus Pharmaceuticals, Inc. · $575.66 · Open Payments source 2025-03-13 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-03-13 · Tarsus Pharmaceuticals, Inc. · $306.66 · Open Payments source 2025-03-26 · Tarsus Pharmaceuticals, Inc. · $300.78 · Open Payments source 2025-03-26 · Tarsus Pharmaceuticals, Inc. · $33.00 · Open Payments source 2025-03-26 · Tarsus Pharmaceuticals, Inc. · $550.96 · Open Payments source 2025-03-26 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-03-27 · Tarsus Pharmaceuticals, Inc. · $52.25 · Open Payments source 2025-04-03 · Tarsus Pharmaceuticals, Inc. · $33.00 · Open Payments source 2025-04-04 · Tarsus Pharmaceuticals, Inc. · $48.02 · Open Payments source 2025-04-04 · Tarsus Pharmaceuticals, Inc. · $303.46 · Open Payments source 2025-04-04 · Tarsus Pharmaceuticals, Inc. · $68.22 · Open Payments source 2025-04-04 · Tarsus Pharmaceuticals, Inc. · $688.17 · Open Payments source 2025-04-04 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-04-10 · Tarsus Pharmaceuticals, Inc. · $33.09 · Open Payments source 2025-05-14 · Tarsus Pharmaceuticals, Inc. · $33.00 · Open Payments source 2025-05-14 · Tarsus Pharmaceuticals, Inc. · $177.99 · Open Payments source 2025-05-14 · Tarsus Pharmaceuticals, Inc. · $5.19 · Open Payments source 2025-05-14 · Tarsus Pharmaceuticals, Inc. · $34.68 · Open Payments source 2025-05-14 · Tarsus Pharmaceuticals, Inc. · $236.96 · Open Payments source 2025-05-14 · Tarsus Pharmaceuticals, Inc. · $268.97 · Open Payments source 2025-05-14 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-05-20 · Tarsus Pharmaceuticals, Inc. · $8.95 · Open Payments source 2025-05-20 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-05-20 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-05-28 · Tarsus Pharmaceuticals, Inc. · $187.96 · Open Payments source 2025-05-28 · Tarsus Pharmaceuticals, Inc. · $219.50 · Open Payments source 2025-05-28 · Tarsus Pharmaceuticals, Inc. · $33.00 · Open Payments source 2025-05-28 · Tarsus Pharmaceuticals, Inc. · $195.94 · Open Payments source 2025-05-28 · Tarsus Pharmaceuticals, Inc. · $16.40 · Open Payments source 2025-05-28 · Tarsus Pharmaceuticals, Inc. · $23.69 · Open Payments source 2025-06-04 · Tarsus Pharmaceuticals, Inc. · $440.96 · Open Payments source 2025-06-04 · Tarsus Pharmaceuticals, Inc. · $175.82 · Open Payments source 2025-06-04 · Tarsus Pharmaceuticals, Inc. · $43.00 · Open Payments source 2025-06-04 · Tarsus Pharmaceuticals, Inc. · $105.70 · Open Payments source 2025-06-04 · Tarsus Pharmaceuticals, Inc. · $12.37 · Open Payments source 2025-06-04 · Tarsus Pharmaceuticals, Inc. · $51.34 · Open Payments source 2025-06-11 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-06-17 · Tarsus Pharmaceuticals, Inc. · $537.36 · Open Payments source 2025-06-17 · Tarsus Pharmaceuticals, Inc. · $6.96 · Open Payments source 2025-06-17 · Tarsus Pharmaceuticals, Inc. · $42.00 · Open Payments source 2025-06-17 · Tarsus Pharmaceuticals, Inc. · $75.35 · Open Payments source 2025-06-17 · Tarsus Pharmaceuticals, Inc. · $40.19 · Open Payments source 2025-06-17 · Tarsus Pharmaceuticals, Inc. · $7.02 · Open Payments source 2025-06-17 · Tarsus Pharmaceuticals, Inc. · $226.44 · Open Payments source 2025-06-18 · Tarsus Pharmaceuticals, Inc. · $4.54 · Open Payments source 2025-07-29 · Tarsus Pharmaceuticals, Inc. · $6.99 · Open Payments source 2025-07-30 · Tarsus Pharmaceuticals, Inc. · $66.00 · Open Payments source 2025-07-30 · Tarsus Pharmaceuticals, Inc. · $500.36 · Open Payments source 2025-07-30 · Tarsus Pharmaceuticals, Inc. · $40.19 · Open Payments source 2025-07-30 · Tarsus Pharmaceuticals, Inc. · $28.34 · Open Payments source 2025-07-30 · Tarsus Pharmaceuticals, Inc. · $329.46 · Open Payments source 2025-07-30 · Tarsus Pharmaceuticals, Inc. · $190.11 · Open Payments source 2025-07-30 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-08-15 · Tarsus Pharmaceuticals, Inc. · $39.38 · Open Payments source 2025-08-20 · Tarsus Pharmaceuticals, Inc. · $57.85 · Open Payments source 2025-08-20 · Tarsus Pharmaceuticals, Inc. · $33.00 · Open Payments source 2025-08-20 · Tarsus Pharmaceuticals, Inc. · $10.08 · Open Payments source 2025-08-20 · Tarsus Pharmaceuticals, Inc. · $2.99 · Open Payments source 2025-08-20 · Tarsus Pharmaceuticals, Inc. · $196.97 · Open Payments source 2025-08-20 · Tarsus Pharmaceuticals, Inc. · $154.52 · Open Payments source 2025-08-20 · Tarsus Pharmaceuticals, Inc. · $151.93 · Open Payments source 2025-08-20 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-08-28 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-09-03 · Tarsus Pharmaceuticals, Inc. · $52.28 · Open Payments source 2025-09-03 · Tarsus Pharmaceuticals, Inc. · $49.46 · Open Payments source 2025-09-03 · Tarsus Pharmaceuticals, Inc. · $33.00 · Open Payments source 2025-09-03 · Tarsus Pharmaceuticals, Inc. · $361.95 · Open Payments source 2025-09-03 · Tarsus Pharmaceuticals, Inc. · $236.97 · Open Payments source 2025-09-10 · Tarsus Pharmaceuticals, Inc. · $86.00 · Open Payments source 2025-09-10 · Tarsus Pharmaceuticals, Inc. · $70.96 · Open Payments source 2025-09-10 · Tarsus Pharmaceuticals, Inc. · $49.61 · Open Payments source 2025-09-10 · Tarsus Pharmaceuticals, Inc. · $416.67 · Open Payments source 2025-09-10 · Tarsus Pharmaceuticals, Inc. · $14.94 · Open Payments source 2025-09-10 · Tarsus Pharmaceuticals, Inc. · $3.75 · Open Payments source 2025-09-10 · Tarsus Pharmaceuticals, Inc. · $219.22 · Open Payments source 2025-09-10 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-09-10 · Tarsus Pharmaceuticals, Inc. · $13.62 · Open Payments source 2025-09-24 · Tarsus Pharmaceuticals, Inc. · $457.49 · Open Payments source 2025-09-24 · Tarsus Pharmaceuticals, Inc. · $3.23 · Open Payments source 2025-09-24 · Tarsus Pharmaceuticals, Inc. · $33.00 · Open Payments source 2025-09-24 · Tarsus Pharmaceuticals, Inc. · $233.51 · Open Payments source 2025-09-24 · Tarsus Pharmaceuticals, Inc. · $14.16 · Open Payments source 2025-09-24 · Tarsus Pharmaceuticals, Inc. · $71.71 · Open Payments source 2025-09-25 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-09-25 · Tarsus Pharmaceuticals, Inc. · $5.93 · Open Payments source 2025-10-01 · Tarsus Pharmaceuticals, Inc. · $33.00 · Open Payments source 2025-10-01 · Tarsus Pharmaceuticals, Inc. · $46.45 · Open Payments source 2025-10-01 · Tarsus Pharmaceuticals, Inc. · $29.04 · Open Payments source 2025-10-01 · Tarsus Pharmaceuticals, Inc. · $182.31 · Open Payments source 2025-10-01 · Tarsus Pharmaceuticals, Inc. · $410.97 · Open Payments source 2025-10-02 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-10-07 · Tarsus Pharmaceuticals, Inc. · $8.69 · Open Payments source 2025-10-22 · Tarsus Pharmaceuticals, Inc. · $39.97 · Open Payments source 2025-10-22 · Tarsus Pharmaceuticals, Inc. · $500.00 · Open Payments source 2025-10-29 · Tarsus Pharmaceuticals, Inc. · $7.60 · Open Payments source 2025-10-29 · Tarsus Pharmaceuticals, Inc. · $274.40 · Open Payments source 2025-10-29 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-10-29 · Tarsus Pharmaceuticals, Inc. · $123.89 · Open Payments source 2025-10-30 · Tarsus Pharmaceuticals, Inc. · $7.61 · Open Payments source 2025-11-05 · Tarsus Pharmaceuticals, Inc. · $8.89 · Open Payments source 2025-11-18 · Tarsus Pharmaceuticals, Inc. · $7.22 · Open Payments source 2025-12-03 · Tarsus Pharmaceuticals, Inc. · $124.29 · Open Payments source 2025-12-03 · Tarsus Pharmaceuticals, Inc. · $386.46 · Open Payments source 2025-12-03 · Tarsus Pharmaceuticals, Inc. · $66.00 · Open Payments source 2025-12-03 · Tarsus Pharmaceuticals, Inc. · $106.53 · Open Payments source 2025-12-03 · Tarsus Pharmaceuticals, Inc. · $37.17 · Open Payments source 2025-12-03 · Tarsus Pharmaceuticals, Inc. · $10.17 · Open Payments source 2025-12-03 · Tarsus Pharmaceuticals, Inc. · $4.17 · Open Payments source 2025-12-03 · Tarsus Pharmaceuticals, Inc. · $4,500.00 · Open Payments source 2025-12-03 · Tarsus Pharmaceuticals, Inc. · $712.67 · Open Payments source 2025-12-05 · Tarsus Pharmaceuticals, Inc. · $38.64 · Open Payments source
MIEBO Normalized: miebo	Drug	Bausch & Lomb Americas Inc.	$81,444.90	116	2025
Source payment records 2025-01-29 · Bausch & Lomb Americas Inc. · $52.92 · Open Payments source 2025-01-29 · Bausch & Lomb Americas Inc. · $125.00 · Open Payments source 2025-01-30 · Bausch & Lomb Americas Inc. · $12.13 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $33.00 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $43.95 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $36.58 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $236.60 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $47.11 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $10.48 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $122.20 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $50.74 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $187.17 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $20.00 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $20.00 · Open Payments source 2025-02-11 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-02-12 · Bausch & Lomb Americas Inc. · $18.93 · Open Payments source 2025-02-19 · Bausch & Lomb Americas Inc. · $22.29 · Open Payments source 2025-02-21 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-02-26 · Bausch & Lomb Americas Inc. · $100.00 · Open Payments source 2025-02-26 · Bausch & Lomb Americas Inc. · $27.09 · Open Payments source 2025-03-07 · Bausch & Lomb Americas Inc. · $6.66 · Open Payments source 2025-03-11 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-03-13 · Bausch & Lomb Americas Inc. · $65.99 · Open Payments source 2025-03-18 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-04-07 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $7.40 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $176.00 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $256.97 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $33.00 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $42.18 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $152.81 · Open Payments source 2025-05-07 · Bausch & Lomb Americas Inc. · $125.00 · Open Payments source 2025-05-07 · Bausch & Lomb Americas Inc. · $9.62 · Open Payments source 2025-05-07 · Bausch & Lomb Americas Inc. · $190.75 · Open Payments source 2025-05-12 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-05-16 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-05-16 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-05-28 · Bausch & Lomb Americas Inc. · $600.00 · Open Payments source 2025-06-05 · Bausch & Lomb Americas Inc. · $1,200.00 · Open Payments source 2025-06-23 · Bausch & Lomb Americas Inc. · $1,200.00 · Open Payments source 2025-07-10 · Bausch & Lomb Americas Inc. · $1,200.00 · Open Payments source 2025-07-17 · Bausch & Lomb Americas Inc. · $4.68 · Open Payments source 2025-07-17 · Bausch & Lomb Americas Inc. · $9.64 · Open Payments source 2025-07-31 · Bausch & Lomb Americas Inc. · $1,800.00 · Open Payments source 2025-08-04 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-08-09 · Bausch & Lomb Americas Inc. · $5.31 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $20.74 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $54.76 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $33.46 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $291.96 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $9.40 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $649.79 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $12.34 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $8.98 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $39.00 · Open Payments source 2025-08-29 · Bausch & Lomb Americas Inc. · $17.85 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $35.06 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $7.40 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $83.00 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $14.05 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $25.95 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $13.23 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $42.88 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $257.18 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $155.18 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $307.52 · Open Payments source 2025-09-11 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-09-11 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $78.99 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $12.05 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $12.05 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $80.33 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $99.07 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $178.49 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $36.00 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $39.40 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $14.27 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $10.84 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $72.94 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $213.30 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $261.71 · Open Payments source 2025-09-24 · Bausch & Lomb Americas Inc. · $4.47 · Open Payments source 2025-10-02 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-10-02 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-10-09 · Bausch & Lomb Americas Inc. · $53.27 · Open Payments source 2025-10-09 · Bausch & Lomb Americas Inc. · $3,100.00 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $62.97 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $47.05 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $55.85 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $33.00 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $225.98 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $251.96 · Open Payments source 2025-10-16 · Bausch & Lomb Americas Inc. · $1,200.00 · Open Payments source 2025-10-16 · Bausch & Lomb Americas Inc. · $105.39 · Open Payments source 2025-10-16 · Bausch & Lomb Americas Inc. · $11.62 · Open Payments source 2025-10-21 · Bausch & Lomb Americas Inc. · $124.99 · Open Payments source 2025-10-21 · Bausch & Lomb Americas Inc. · $48.72 · Open Payments source 2025-10-22 · Bausch & Lomb Americas Inc. · $900.00 · Open Payments source 2025-10-23 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-10-23 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-10-29 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-11-22 · Bausch & Lomb Americas Inc. · $344.51 · Open Payments source 2025-11-23 · Bausch & Lomb Americas Inc. · $145.60 · Open Payments source 2025-12-04 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $81.69 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $138.48 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $39.62 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $112.72 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $202.48 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $33.00 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $47.00 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $202.74 · Open Payments source 2025-12-10 · Bausch & Lomb Americas Inc. · $7.78 · Open Payments source 2025-12-18 · Bausch & Lomb Americas Inc. · $13.66 · Open Payments source 2025-12-18 · Bausch & Lomb Americas Inc. · $8.98 · Open Payments source 2025-12-18 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source
XIIDRA Normalized: xiidra	Drug	Bausch & Lomb Americas Inc.	$75,179.80	100	2025
Source payment records 2025-01-29 · Bausch & Lomb Americas Inc. · $52.92 · Open Payments source 2025-01-29 · Bausch & Lomb Americas Inc. · $125.00 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $33.00 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $43.95 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $36.58 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $236.60 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $47.11 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $10.48 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $122.20 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $50.74 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $187.17 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $20.00 · Open Payments source 2025-02-06 · Bausch & Lomb Americas Inc. · $20.00 · Open Payments source 2025-02-11 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-02-12 · Bausch & Lomb Americas Inc. · $18.93 · Open Payments source 2025-02-21 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-02-26 · Bausch & Lomb Americas Inc. · $100.00 · Open Payments source 2025-02-26 · Bausch & Lomb Americas Inc. · $27.09 · Open Payments source 2025-03-11 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-03-13 · Bausch & Lomb Americas Inc. · $65.99 · Open Payments source 2025-03-18 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-03-31 · Bausch & Lomb Americas Inc. · $8.24 · Open Payments source 2025-04-07 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $176.00 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $256.97 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $33.00 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $42.18 · Open Payments source 2025-04-23 · Bausch & Lomb Americas Inc. · $152.81 · Open Payments source 2025-05-07 · Bausch & Lomb Americas Inc. · $125.00 · Open Payments source 2025-05-07 · Bausch & Lomb Americas Inc. · $9.62 · Open Payments source 2025-05-07 · Bausch & Lomb Americas Inc. · $190.75 · Open Payments source 2025-05-12 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-05-12 · Bausch & Lomb Americas Inc. · $8.43 · Open Payments source 2025-05-14 · Bausch & Lomb Americas Inc. · $300.00 · Open Payments source 2025-05-16 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-05-16 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-05-28 · Bausch & Lomb Americas Inc. · $600.00 · Open Payments source 2025-06-05 · Bausch & Lomb Americas Inc. · $1,200.00 · Open Payments source 2025-06-23 · Bausch & Lomb Americas Inc. · $1,200.00 · Open Payments source 2025-06-27 · Bausch & Lomb Americas Inc. · $74.71 · Open Payments source 2025-06-27 · Bausch & Lomb Americas Inc. · $25.82 · Open Payments source 2025-07-10 · Bausch & Lomb Americas Inc. · $1,200.00 · Open Payments source 2025-07-16 · Bausch & Lomb Americas Inc. · $1,200.00 · Open Payments source 2025-07-31 · Bausch & Lomb Americas Inc. · $1,800.00 · Open Payments source 2025-08-04 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $1,500.00 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $35.06 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $7.40 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $83.00 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $14.05 · Open Payments source 2025-09-04 · Bausch & Lomb Americas Inc. · $25.95 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $13.23 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $42.88 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $257.18 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $155.18 · Open Payments source 2025-09-05 · Bausch & Lomb Americas Inc. · $307.52 · Open Payments source 2025-09-11 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $78.99 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $12.05 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $12.05 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $80.33 · Open Payments source 2025-09-20 · Bausch & Lomb Americas Inc. · $99.07 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $178.49 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $36.00 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $39.40 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $14.27 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $10.84 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $72.94 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $213.30 · Open Payments source 2025-09-23 · Bausch & Lomb Americas Inc. · $261.71 · Open Payments source 2025-09-24 · Bausch & Lomb Americas Inc. · $4.47 · Open Payments source 2025-10-02 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-10-09 · Bausch & Lomb Americas Inc. · $3,100.00 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $62.97 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $47.05 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $55.85 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $33.00 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $225.98 · Open Payments source 2025-10-15 · Bausch & Lomb Americas Inc. · $251.96 · Open Payments source 2025-10-16 · Bausch & Lomb Americas Inc. · $1,200.00 · Open Payments source 2025-10-16 · Bausch & Lomb Americas Inc. · $105.39 · Open Payments source 2025-10-16 · Bausch & Lomb Americas Inc. · $11.62 · Open Payments source 2025-10-21 · Bausch & Lomb Americas Inc. · $124.99 · Open Payments source 2025-10-21 · Bausch & Lomb Americas Inc. · $48.72 · Open Payments source 2025-10-23 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-10-23 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-10-29 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-11-22 · Bausch & Lomb Americas Inc. · $344.51 · Open Payments source 2025-11-23 · Bausch & Lomb Americas Inc. · $145.60 · Open Payments source 2025-12-04 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $81.69 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $138.48 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $39.62 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $112.72 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $202.48 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $33.00 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $47.00 · Open Payments source 2025-12-09 · Bausch & Lomb Americas Inc. · $202.74 · Open Payments source 2025-12-10 · Bausch & Lomb Americas Inc. · $7.78 · Open Payments source 2025-12-18 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source
TRYPTYR Normalized: tryptyr	Drug	Alcon Research LLC, Alcon Vision LLC	$34,368.11	35	2025
Source payment records 2025-04-24 · Alcon Vision LLC · $1,000.00 · Open Payments source 2025-07-10 · Alcon Research LLC · $750.00 · Open Payments source 2025-07-14 · Alcon Vision LLC · $15.37 · Open Payments source 2025-07-18 · Alcon Vision LLC · $276.96 · Open Payments source 2025-08-05 · Alcon Vision LLC · $7.13 · Open Payments source 2025-08-07 · Alcon Vision LLC · $6,500.00 · Open Payments source 2025-08-07 · Alcon Vision LLC · $39.00 · Open Payments source 2025-08-18 · Alcon Vision LLC · $16.42 · Open Payments source 2025-09-18 · Alcon Vision LLC · $2,187.50 · Open Payments source 2025-09-22 · Alcon Vision LLC · $5.95 · Open Payments source 2025-10-09 · Alcon Vision LLC · $2,187.50 · Open Payments source 2025-10-09 · Alcon Vision LLC · $3,437.50 · Open Payments source 2025-10-20 · Alcon Vision LLC · $21.06 · Open Payments source 2025-10-23 · Alcon Research LLC · $5,625.00 · Open Payments source 2025-11-05 · Alcon Vision LLC · $286.48 · Open Payments source 2025-11-05 · Alcon Vision LLC · $317.48 · Open Payments source 2025-11-05 · Alcon Vision LLC · $280.88 · Open Payments source 2025-11-06 · Alcon Vision LLC · $116.19 · Open Payments source 2025-11-11 · Alcon Vision LLC · $84.90 · Open Payments source 2025-11-11 · Alcon Vision LLC · $352.48 · Open Payments source 2025-11-11 · Alcon Vision LLC · $258.68 · Open Payments source 2025-11-20 · Alcon Vision LLC · $36.13 · Open Payments source 2025-11-20 · Alcon Vision LLC · $30.55 · Open Payments source 2025-11-20 · Alcon Vision LLC · $15.37 · Open Payments source 2025-11-20 · Alcon Vision LLC · $4,062.50 · Open Payments source 2025-11-20 · Alcon Vision LLC · $2,187.50 · Open Payments source 2025-11-20 · Alcon Vision LLC · $4,062.50 · Open Payments source 2025-11-20 · Alcon Vision LLC · $33.00 · Open Payments source 2025-11-20 · Alcon Vision LLC · $33.35 · Open Payments source 2025-11-20 · Alcon Vision LLC · $35.12 · Open Payments source 2025-11-20 · Alcon Vision LLC · $17.43 · Open Payments source 2025-11-20 · Alcon Vision LLC · $7.84 · Open Payments source 2025-11-20 · Alcon Vision LLC · $38.00 · Open Payments source 2025-11-20 · Alcon Vision LLC · $14.81 · Open Payments source 2025-11-20 · Alcon Vision LLC · $27.53 · Open Payments source
OXERVATE Normalized: oxervate	Drug	Dompe US, Inc.	$24,686.00	36	2025
Source payment records 2025-02-24 · Dompe US, Inc. · $12.77 · Open Payments source 2025-03-24 · Dompe US, Inc. · $750.00 · Open Payments source 2025-04-01 · Dompe US, Inc. · $13.49 · Open Payments source 2025-04-01 · Dompe US, Inc. · $6.05 · Open Payments source 2025-04-01 · Dompe US, Inc. · $98.90 · Open Payments source 2025-04-01 · Dompe US, Inc. · $99.47 · Open Payments source 2025-04-01 · Dompe US, Inc. · $33.00 · Open Payments source 2025-04-01 · Dompe US, Inc. · $125.00 · Open Payments source 2025-04-01 · Dompe US, Inc. · $242.74 · Open Payments source 2025-04-01 · Dompe US, Inc. · $51.67 · Open Payments source 2025-04-09 · Dompe US, Inc. · $329.96 · Open Payments source 2025-04-15 · Dompe US, Inc. · $4,200.00 · Open Payments source 2025-06-23 · Dompe US, Inc. · $14.36 · Open Payments source 2025-06-25 · Dompe US, Inc. · $120.90 · Open Payments source 2025-06-27 · Dompe US, Inc. · $2,400.00 · Open Payments source 2025-07-23 · Dompe US, Inc. · $273.00 · Open Payments source 2025-07-29 · Dompe US, Inc. · $4,200.00 · Open Payments source 2025-08-13 · Dompe US, Inc. · $230.20 · Open Payments source 2025-08-13 · Dompe US, Inc. · $61.96 · Open Payments source 2025-08-13 · Dompe US, Inc. · $43.49 · Open Payments source 2025-08-13 · Dompe US, Inc. · $45.74 · Open Payments source 2025-08-13 · Dompe US, Inc. · $146.34 · Open Payments source 2025-08-13 · Dompe US, Inc. · $196.97 · Open Payments source 2025-08-13 · Dompe US, Inc. · $33.00 · Open Payments source 2025-08-21 · Dompe US, Inc. · $4,200.00 · Open Payments source 2025-10-07 · Dompe US, Inc. · $60.68 · Open Payments source 2025-10-07 · Dompe US, Inc. · $529.97 · Open Payments source 2025-10-07 · Dompe US, Inc. · $58.49 · Open Payments source 2025-10-10 · Dompe US, Inc. · $123.32 · Open Payments source 2025-10-10 · Dompe US, Inc. · $15.96 · Open Payments source 2025-10-10 · Dompe US, Inc. · $418.06 · Open Payments source 2025-10-10 · Dompe US, Inc. · $20.30 · Open Payments source 2025-10-12 · Dompe US, Inc. · $45.40 · Open Payments source 2025-10-12 · Dompe US, Inc. · $53.82 · Open Payments source 2025-10-17 · Dompe US, Inc. · $5,400.00 · Open Payments source 2025-11-17 · Dompe US, Inc. · $30.99 · Open Payments source
VEVYE Normalized: vevye	Drug	Harrow Eye, LLC	$16,963.83	12	2025
Source payment records 2025-02-07 · Harrow Eye, LLC · $9.86 · Open Payments source 2025-05-21 · Harrow Eye, LLC · $48.81 · Open Payments source 2025-05-21 · Harrow Eye, LLC · $23.20 · Open Payments source 2025-05-30 · Harrow Eye, LLC · $4,750.00 · Open Payments source 2025-06-29 · Harrow Eye, LLC · $107.24 · Open Payments source 2025-06-29 · Harrow Eye, LLC · $578.96 · Open Payments source 2025-06-29 · Harrow Eye, LLC · $48.00 · Open Payments source 2025-11-13 · Harrow Eye, LLC · $113.51 · Open Payments source 2025-11-13 · Harrow Eye, LLC · $649.96 · Open Payments source 2025-11-13 · Harrow Eye, LLC · $293.94 · Open Payments source 2025-11-13 · Harrow Eye, LLC · $10,100.00 · Open Payments source 2025-11-13 · Harrow Eye, LLC · $240.35 · Open Payments source
Cequa Normalized: cequa	Drug	SUN PHARMACEUTICAL INDUSTRIES INC.	$15,770.95	41	2025
Source payment records 2025-01-10 · SUN PHARMACEUTICAL INDUSTRIES INC. · $25.62 · Open Payments source 2025-01-21 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.62 · Open Payments source 2025-02-07 · SUN PHARMACEUTICAL INDUSTRIES INC. · $33.00 · Open Payments source 2025-02-07 · SUN PHARMACEUTICAL INDUSTRIES INC. · $28.72 · Open Payments source 2025-02-07 · SUN PHARMACEUTICAL INDUSTRIES INC. · $45.49 · Open Payments source 2025-02-07 · SUN PHARMACEUTICAL INDUSTRIES INC. · $30.91 · Open Payments source 2025-02-07 · SUN PHARMACEUTICAL INDUSTRIES INC. · $52.54 · Open Payments source 2025-02-07 · SUN PHARMACEUTICAL INDUSTRIES INC. · $38.54 · Open Payments source 2025-03-17 · SUN PHARMACEUTICAL INDUSTRIES INC. · $9.22 · Open Payments source 2025-03-17 · SUN PHARMACEUTICAL INDUSTRIES INC. · $3.70 · Open Payments source 2025-04-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.83 · Open Payments source 2025-05-05 · SUN PHARMACEUTICAL INDUSTRIES INC. · $5.27 · Open Payments source 2025-05-12 · SUN PHARMACEUTICAL INDUSTRIES INC. · $1,200.00 · Open Payments source 2025-05-16 · SUN PHARMACEUTICAL INDUSTRIES INC. · $1.82 · Open Payments source 2025-05-16 · SUN PHARMACEUTICAL INDUSTRIES INC. · $20.00 · Open Payments source 2025-06-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $4,500.00 · Open Payments source 2025-06-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $179.41 · Open Payments source 2025-06-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $771.79 · Open Payments source 2025-06-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $311.96 · Open Payments source 2025-06-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $500.97 · Open Payments source 2025-06-19 · SUN PHARMACEUTICAL INDUSTRIES INC. · $4,500.00 · Open Payments source 2025-06-19 · SUN PHARMACEUTICAL INDUSTRIES INC. · $311.95 · Open Payments source 2025-06-27 · SUN PHARMACEUTICAL INDUSTRIES INC. · $7.98 · Open Payments source 2025-07-23 · SUN PHARMACEUTICAL INDUSTRIES INC. · $19.53 · Open Payments source 2025-07-23 · SUN PHARMACEUTICAL INDUSTRIES INC. · $34.24 · Open Payments source 2025-07-23 · SUN PHARMACEUTICAL INDUSTRIES INC. · $42.00 · Open Payments source 2025-07-23 · SUN PHARMACEUTICAL INDUSTRIES INC. · $40.19 · Open Payments source 2025-07-23 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.31 · Open Payments source 2025-08-04 · SUN PHARMACEUTICAL INDUSTRIES INC. · $3.69 · Open Payments source 2025-08-04 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.79 · Open Payments source 2025-08-11 · SUN PHARMACEUTICAL INDUSTRIES INC. · $28.07 · Open Payments source 2025-08-28 · SUN PHARMACEUTICAL INDUSTRIES INC. · $2,700.00 · Open Payments source 2025-08-28 · SUN PHARMACEUTICAL INDUSTRIES INC. · $117.29 · Open Payments source 2025-10-02 · SUN PHARMACEUTICAL INDUSTRIES INC. · $17.40 · Open Payments source 2025-10-02 · SUN PHARMACEUTICAL INDUSTRIES INC. · $18.35 · Open Payments source 2025-10-02 · SUN PHARMACEUTICAL INDUSTRIES INC. · $42.00 · Open Payments source 2025-10-02 · SUN PHARMACEUTICAL INDUSTRIES INC. · $48.49 · Open Payments source 2025-10-22 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.99 · Open Payments source 2025-11-21 · SUN PHARMACEUTICAL INDUSTRIES INC. · $26.30 · Open Payments source 2025-12-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $2.21 · Open Payments source 2025-12-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.76 · Open Payments source
VYZULTA Normalized: vyzulta	Drug	Bausch & Lomb Americas Inc.	$8,770.43	12	2025
Source payment records 2025-07-10 · Bausch & Lomb Americas Inc. · $450.00 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $20.74 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $54.76 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $33.46 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $291.96 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $9.40 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $649.79 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $12.34 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $8.98 · Open Payments source 2025-08-27 · Bausch & Lomb Americas Inc. · $39.00 · Open Payments source 2025-09-11 · Bausch & Lomb Americas Inc. · $4,800.00 · Open Payments source 2025-10-02 · Bausch & Lomb Americas Inc. · $2,400.00 · Open Payments source
TEARCARE SYSTEM Normalized: tearcare system	Device	Sight Sciences, Inc.	$6,898.97	3	2025
Source payment records 2025-03-06 · Sight Sciences, Inc. · $1,650.00 · Open Payments source 2025-04-03 · Sight Sciences, Inc. · $825.00 · Open Payments source 2025-04-24 · Sight Sciences, Inc. · $4,423.97 · Open Payments source
Xelpros Normalized: xelpros	Drug	SUN PHARMACEUTICAL INDUSTRIES INC.	$177.87	16	2025
Source payment records 2025-01-10 · SUN PHARMACEUTICAL INDUSTRIES INC. · $25.62 · Open Payments source 2025-01-21 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.62 · Open Payments source 2025-03-17 · SUN PHARMACEUTICAL INDUSTRIES INC. · $9.22 · Open Payments source 2025-03-17 · SUN PHARMACEUTICAL INDUSTRIES INC. · $3.70 · Open Payments source 2025-04-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.83 · Open Payments source 2025-05-05 · SUN PHARMACEUTICAL INDUSTRIES INC. · $5.27 · Open Payments source 2025-05-16 · SUN PHARMACEUTICAL INDUSTRIES INC. · $1.82 · Open Payments source 2025-05-16 · SUN PHARMACEUTICAL INDUSTRIES INC. · $20.00 · Open Payments source 2025-06-27 · SUN PHARMACEUTICAL INDUSTRIES INC. · $7.98 · Open Payments source 2025-08-04 · SUN PHARMACEUTICAL INDUSTRIES INC. · $3.69 · Open Payments source 2025-08-04 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.79 · Open Payments source 2025-08-11 · SUN PHARMACEUTICAL INDUSTRIES INC. · $28.07 · Open Payments source 2025-10-22 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.99 · Open Payments source 2025-11-21 · SUN PHARMACEUTICAL INDUSTRIES INC. · $26.30 · Open Payments source 2025-12-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $2.21 · Open Payments source 2025-12-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.76 · Open Payments source
BromSite Normalized: bromsite	Drug	SUN PHARMACEUTICAL INDUSTRIES INC.	$129.34	12	2025
Source payment records 2025-01-10 · SUN PHARMACEUTICAL INDUSTRIES INC. · $25.62 · Open Payments source 2025-01-21 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.62 · Open Payments source 2025-03-17 · SUN PHARMACEUTICAL INDUSTRIES INC. · $9.22 · Open Payments source 2025-03-17 · SUN PHARMACEUTICAL INDUSTRIES INC. · $3.70 · Open Payments source 2025-04-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.83 · Open Payments source 2025-05-05 · SUN PHARMACEUTICAL INDUSTRIES INC. · $5.27 · Open Payments source 2025-05-16 · SUN PHARMACEUTICAL INDUSTRIES INC. · $1.82 · Open Payments source 2025-05-16 · SUN PHARMACEUTICAL INDUSTRIES INC. · $20.00 · Open Payments source 2025-10-22 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.99 · Open Payments source 2025-11-21 · SUN PHARMACEUTICAL INDUSTRIES INC. · $26.30 · Open Payments source 2025-12-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $2.21 · Open Payments source 2025-12-18 · SUN PHARMACEUTICAL INDUSTRIES INC. · $8.76 · Open Payments source
INFUSE Normalized: infuse	Device	Bausch & Lomb Americas Inc.	$111.81	1	2025
Source payment records 2025-07-09 · Bausch & Lomb Americas Inc. · $111.81 · Open Payments source
EYSUVIS Normalized: eysuvis	Drug	Alcon Vision LLC	$53.68	3	2025
Source payment records 2025-01-31 · Alcon Vision LLC · $30.16 · Open Payments source 2025-05-07 · Alcon Vision LLC · $16.10 · Open Payments source 2025-05-20 · Alcon Vision LLC · $7.42 · Open Payments source
LIGHT ADJUSTABLE LENS (LAL) Normalized: light adjustable lens lal	Device	RxSight Inc	$42.84	2	2025
Source payment records 2025-10-02 · RxSight Inc · $24.52 · Open Payments source 2025-10-23 · RxSight Inc · $18.32 · Open Payments source
RXSIGHT CONTACT LENS Normalized: rxsight contact lens	Device	RxSight Inc	$42.84	2	2025
Source payment records 2025-10-02 · RxSight Inc · $24.52 · Open Payments source 2025-10-23 · RxSight Inc · $18.32 · Open Payments source
RXSIGHT INJECTOR CARTRIDGE Normalized: rxsight injector cartridge	Device	RxSight Inc	$42.84	2	2025
Source payment records 2025-10-02 · RxSight Inc · $24.52 · Open Payments source 2025-10-23 · RxSight Inc · $18.32 · Open Payments source
RXSIGHT INJECTOR HANDPIECE Normalized: rxsight injector handpiece	Device	RxSight Inc	$42.84	2	2025
Source payment records 2025-10-02 · RxSight Inc · $24.52 · Open Payments source 2025-10-23 · RxSight Inc · $18.32 · Open Payments source
RXSIGHT LIGHT DELIVERY DEVICE (LDD) Normalized: rxsight light delivery device ldd	Device	RxSight Inc	$42.84	2	2025
Source payment records 2025-10-02 · RxSight Inc · $24.52 · Open Payments source 2025-10-23 · RxSight Inc · $18.32 · Open Payments source
Clareon PanOptix Pro Normalized: clareon panoptix pro	Device	Alcon Vision LLC	$25.15	1	2025
Source payment records 2025-08-13 · Alcon Vision LLC · $25.15 · Open Payments source
ScoutPro Osmolarity System Normalized: scoutpro osmolarity system	Device	Bausch & Lomb Americas Inc.	$22.20	1	2025
Source payment records 2025-11-14 · Bausch & Lomb Americas Inc. · $22.20 · Open Payments source
Precision 1 Normalized: precision 1	Device	Alcon Vision LLC	$19.98	1	2025
Source payment records 2025-04-03 · Alcon Vision LLC · $19.98 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Cequa cequa	2025	Cequa	2024	33	exact normalized	Medicare Part D
MIEBO miebo	2025	Miebo	2024	52	exact normalized	Medicare Part D
OXERVATE oxervate	2025	Oxervate	2024	24 Beneficiary count suppressed	exact normalized	Medicare Part D
XDEMVY xdemvy	2025	Xdemvy	2024	93	exact normalized	Medicare Part D
XIIDRA xiidra	2025	Xiidra	2024	21 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LUMIGAN open payments reported associated product	CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548	Lumigan · 2024 Exact normalized brand match · 1 Part D row	26	suppressed by CMS
Bausch & Lomb Americas Inc. Exact reporting entity; no affiliate inference	2025	MIEBO open payments reported associated product	CMS Open Payments — General Payments 34133 supporting records · 12967 recipient NPIs · example record 1254730224	Miebo · 2024 Exact normalized brand match · 1 Part D row	52	25
Bausch & Lomb Americas Inc. Exact reporting entity; no affiliate inference	2025	XIIDRA open payments reported associated product	CMS Open Payments — General Payments 28163 supporting records · 11019 recipient NPIs · example record 1254730224	Xiidra · 2024 Exact normalized brand match · 1 Part D row	21	suppressed by CMS
Dompe US, Inc. Exact reporting entity; no affiliate inference	2025	OXERVATE open payments reported associated product	CMS Open Payments — General Payments 19540 supporting records · 9712 recipient NPIs · example record 1248849978	Oxervate · 2024 Exact normalized brand match · 1 Part D row	24	suppressed by CMS
SUN PHARMACEUTICAL INDUSTRIES INC. Exact reporting entity; no affiliate inference	2025	Cequa open payments reported associated product	CMS Open Payments — General Payments 25765 supporting records · 9461 recipient NPIs · example record 1250962431	Cequa · 2024 Exact normalized brand match · 1 Part D row	33	18
Tarsus Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	XDEMVY open payments reported associated product	CMS Open Payments — General Payments 46638 supporting records · 15254 recipient NPIs · example record 1233825434	Xdemvy · 2024 Exact normalized brand match · 1 Part D row	93	86

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Xdemvy	Lotilaner	93	86
Latanoprost	Latanoprost	63	19
Restasis	Cyclosporine	63	32
Miebo	Perfluorohexyloctane/Pf	52	25
Cequa	Cyclosporine	33	18
Prednisolone Acetate	Prednisolone Acetate	28	27
Lumigan	Bimatoprost	26	suppressed
Oxervate	Cenegermin-Bkbj	24	suppressed
Xiidra	Lifitegrast	21	suppressed
Cyclosporine	Cyclosporine	16	13

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$294,464.50 · 423 records	Tarsus Pharmaceuticals, Inc.	BromSite, Cequa, Clareon PanOptix Pro, EYSUVIS, INFUSE, LIGHT ADJUSTABLE LENS (LAL), MIEBO, OXERVATE, Precision 1, RXSIGHT CONTACT LENS, RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE, RXSIGHT LIGHT DELIVERY DEVICE (LDD), ScoutPro Osmolarity System, TEARCARE SYSTEM, TRYPTYR, VEVYE, VYZULTA, XDEMVY, XIIDRA, Xelpros	6	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Cequa play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error